Göthert M - Search Results

1

The naturally occurring Arg219Leu variant of the human 5-HT1A receptor: impairment of signal transduction.

Brüss M, Kostanian A, Bönisch H, Göthert M. Brüss M, et al. Among authors: gothert m. Pharmacogenet Genomics. 2005 Apr;15(4):257-64. doi: 10.1097/01213011-200504000-00009. Pharmacogenet Genomics. 2005. PMID: 15864118

2

Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.

Kurzwelly D, Barann M, Kostanian A, Combrink S, Bönisch H, Göthert M, Brüss M. Kurzwelly D, et al. Among authors: gothert m. Pharmacogenetics. 2004 Mar;14(3):165-72. doi: 10.1097/00008571-200403000-00004. Pharmacogenetics. 2004. PMID: 15167704

3

Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.

Brüss M, Kiel S, Bönisch H, Kostanian A, Göthert M. Brüss M, et al. Among authors: gothert m. Neurochem Int. 2005 Aug;47(3):196-203. doi: 10.1016/j.neuint.2005.03.003. Neurochem Int. 2005. PMID: 15896881

4

Characterization of the naturally occurring Arg344His variant of the human 5-HT 3A receptor.

Combrink S, Kostanian A, Walstab J, Barann M, Brüss M, Göthert M, Bönisch H. Combrink S, et al. Among authors: gothert m. Pharmacol Rep. 2009 Sep-Oct;61(5):785-97. doi: 10.1016/s1734-1140(09)70134-3. Pharmacol Rep. 2009. PMID: 19904001 Free article.

5

Impairment of signal transduction in response to stimulation of the naturally occurring Pro279Leu variant of the h5-HT7(a) receptor.

Kiel S, Bönisch H, Brüss M, Göthert M. Kiel S, et al. Among authors: gothert m. Pharmacogenetics. 2003 Feb;13(2):119-26. doi: 10.1097/00008571-200302000-00008. Pharmacogenetics. 2003. PMID: 12563181

6

Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor.

Brüss M, Bönisch H, Bühlen M, Nöthen MM, Propping P, Göthert M. Brüss M, et al. Among authors: gothert m. Pharmacogenetics. 1999 Feb;9(1):95-102. Pharmacogenetics. 1999. PMID: 10208648

7

Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HT1B receptor: changes in ligand binding, G-protein coupling and second messenger formation.

Kiel S, Brüss M, Bönisch H, Göthert M. Kiel S, et al. Among authors: gothert m. Pharmacogenetics. 2000 Oct;10(7):655-66. doi: 10.1097/00008571-200010000-00008. Pharmacogenetics. 2000. PMID: 11037806

8

Identification and pharmacological characterization of a specific agmatine transport system in human tumor cell lines.

Molderings GJ, Bruss M, Bonisch H, Gothert M. Molderings GJ, et al. Among authors: gothert m. Ann N Y Acad Sci. 2003 Dec;1009:75-81. doi: 10.1196/annals.1304.008. Ann N Y Acad Sci. 2003. PMID: 15028572

9

Alpha(2A)-adrenergic versus imidazoline receptor controversy in rilmenidine's action: alpha(2A)-antagonism in humans versus alpha(2A)-agonism in rabbits.

Molderings GJ, Bonisch H, Bruss M, Gothert M. Molderings GJ, et al. Among authors: gothert m. Ann N Y Acad Sci. 2003 Dec;1009:279-82. doi: 10.1196/annals.1304.036. Ann N Y Acad Sci. 2003. PMID: 15028600

10

5-Hydroxytryptamine-induced contraction of human temporal arteries coexpressing 5-HT2A receptors and wild-type or variant (Phe124Cys) 5-HT1B receptors: increased contribution of 5-HT1B receptors to the total contractile amplitude in arteries from Phe124Cys heterozygous individuals.

Verheggen R, Werner I, Lücker A, Brüss M, Göthert M, Kaumann AJ. Verheggen R, et al. Among authors: gothert m. Pharmacogenet Genomics. 2006 Aug;16(8):601-7. doi: 10.1097/01.fpc.0000220564.52348.63. Pharmacogenet Genomics. 2006. PMID: 16847428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page